[对大动脉疾病的非侵入性治疗的进展]
1Department of Vascular Surgery, the First Affiliated Hospital, Naval Medical University, Shanghai 200433, China.
Zhonghua wai ke za zhi [Chinese journal of surgery]
|April 29, 2024
概括
由于内血管治疗诊断和预后的挑战,对大动脉疾病的非侵入性策略至关重要. 研究重点是预防,早期药物干预和精确的多omics分析,以获得更好的结果.
科学领域:
- 心血管研究研究心血管研究
- 医疗技术 医疗技术 医学技术
- 基因组学和蛋白质组学
背景情况:
- 大动脉疾病的内血管治疗面临诊断,时间和预后评估的挑战.
- 人们越来越需要有效的非侵入性方法来管理大动脉疾病.
研究的目的:
- 探索预防,诊断,治疗和预测大动脉疾病的非侵入性策略.
- 通过精确的多学科分析,确定最佳的干预时间和治疗策略.
主要方法:
- 专注于患有大动脉剖析的高风险人群和有大动脉扩张家族史的人群.
- 利用药物干预来调节控制大动脉扩张的关键目标和机制.
- 采用精确的多主题分析来实现个性化治疗策略.
主要成果:
- 非侵入性治疗的目的是控制大动脉动脉瘤和剖析进展.
- 有潜力实现长期稳定的共存与大动脉疾病或逆转进展.
- 新的干预媒介可能会导致良性大动脉重塑和愈合.
结论:
- 非侵入性方法为治疗大动脉疾病提供了一个有希望的替代方案.
- 精确,个性化的干预措施可以改善患者的治疗结果和疾病管理.
- 对非侵入性策略的进一步研究对于推进大动脉疾病护理至关重要.
相关概念视频
Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Aortic Regurgitation I: Introduction
1.6K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.6K
Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Peripheral Artery Disease III: Interprofessional Care
655
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
Aneurysm III: Interprofessional Care
478
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478


